Lazy Sunday afternoons: The negative impact of interruptions in patients' daily routine on adherence to oral antidiabetic medication. A multilevel analysis of electronic monitoring data

European Journal of Clinical Pharmacology

Volumn 69, Issue 8, 2013, Pages 1599-1606

  Vervloet, M ^a   Spreeuwenberg, P ^a   Bouvy, M L ^b   Heerdink, E R ^b   De Bakker, D H ^a,c   Van Dijk, L ^a  

^a NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

Author keywords

Electronic monitoring; Medication adherence; Multilevel modelling; Oral antidiabetics

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AUTUMN; CLINICAL TRIAL; DATA ANALYSIS; DRUG EFFECT; DRUG MONITORING; ELECTRONICS; FEMALE; GLYCEMIC CONTROL; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; SPRING; SUMMER; WINTER;

ADMINISTRATION, ORAL; DIABETES MELLITUS, TYPE 2; DRUG MONITORING; ELECTRICAL EQUIPMENT AND SUPPLIES; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTILEVEL ANALYSIS; TIME FACTORS;

EID: 84880508324     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1511-y     Document Type: Article

References (28)

1. Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P et al (2002) A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 16(16):2175-2182
2. Carrieri P, Cailleton V, Le Moing V, Spire B, Dellamonica P, Bouvet E et al (2001) The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr 28(3):232-239
3. Ajit RR, Fenerty CH, Henson DB (2010) Patterns and rate of adherence to glaucoma therapy using an electronic dosing aid. Eye (Lond) 24(8):1338-1343
4. Levine AJ, Hinkin CH, Castellon SA, Mason KI, Lam MN, Perkins A et al (2005) Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav 9(3):355-362
5. Modi AC, Rausch JR, Glauser TA (2011) Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA 305(16):1669-1676
6. Yu PC, Bosnyak Z, Ceriello A (2010) The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. Diabetes Res Clin Pract 89(1):1-9
7. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321(7258):405-412
8. Asche C, LaFleur J, Conner C (2011) A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther 33(1):74-109
9. Paes AH, Bakker A, Soe-Agnie CJ (1997) Impact of dosage frequency on patient compliance. Diabetes Care 20(10):1512-1517
10. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23(8):1296-1310
11. Saini SD, Schoenfeld P, Kaulback K, Dubinsky MC (2009) Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 15(6):e22-e33
12. Winkler A, Teuscher AU, Mueller B, Diem P (2002) Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly 132(27-28):379-385
13. Donnan PT, MacDonald TM, Morris AD (2002) Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med 19(4):279-284
14. Kardas P (2005) The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes). Diabetes Obes Metab 7(6):722-728
15. Comte L, Vrijens B, Tousset E, Gerard P, Urquhart J (2007) Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics. J Pharmacokinet Pharmacodyn 34(4):549-558
16. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M (2008) Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. Br Med J 336(7653):1114-1117
17. Twisk JWR (2006) Applied multilevel analyses. Cambridge University Press, Cambridge
18. Vervloet M, van Dijk L, Santen-Reestman J, van Vlijmen B, Bouvy ML, de Bakker DH (2011) Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminders. BMC Health Serv Res 11:5
19. Vervloet M, van Dijk L, Santen-Reestman J, van Vlijmen B, van WingerdenWP, Bouvy ML et al (2012) SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored. Int J Med Inform 81(9):594-604
20. Rasbash J, Charlton C, Browne WJ, Healy M, Cameron B (2009) MLwiN Version 2.1. Centre for Multilevel Modelling, University of Bristol
21. Lawton J, Peel E, Parry O, Douglas M (2008) Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study. Diabet Med 25(4):491-495
22. van Dijk L, Heerdink ER, Somai D, van Dulmen S, Sluijs EM, de Ridder DT et al (2007) Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res 7:51
23. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487-497
24. Park DC, Hertzog C, Leventhal H, Morrell RW, Leventhal E, Birchmore D et al (1999) Medication adherence in rheumatoid arthritis patients: older is wiser. J Am Geriatr Soc 47(2):172-183
25. Vrijens B, Goetghebeur E (1999) The impact of compliance in pharmacokinetic studies. Stat Methods Med Res 8(3):247-262
26. Girard P, Sheiner LB, Kastrissios H, Blaschke TF (1996) Do we need full compliance data for population pharmacokinetic analysis? J Pharmacokinet Biopharm 24(3):265-282
27. Rubio A, Cox C, Weintraub M (1992) Prediction of diltiazem plasma concentration curves from limited measurements using compliance data. Clin Pharmacokinet 22(3):238-246
28. Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA (2004) Electronic monitoring and counseling to improve medication adherence. Behav Res Ther 42(4):409-422